Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy

BACKGROUND: Dual antiplatelet therapy using acetylsalicylic acid (ASA, aspirin) and clopidogrel is of great importance following coronary stenting. However, the variable platelet inhibitory effectiveness compromises the antithrombotic advantages provided by dual antiplatelet therapy. The aim of this...

Full description

Saved in:
Bibliographic Details
Main Authors: Neubauer, Horst, Kaiser, Andreas FC, Endres, Heinz G, Krüger, Jan C, Engelhardt, Andreas, Lask, Sebastian, Pepinghege, Fenena, Kusber, Andreas, Mügge, Andreas
Format: Artigo
Language:Inglês
Published: BioMed Central 2011
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3033359/
https://ncbi.nlm.nih.gov/pubmed/21226927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-9-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items